RT Journal Article
SR Electronic
T1 Accurate prediction of neurologic changes in critically ill infants using pose AI
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.17.24305953
DO 10.1101/2024.04.17.24305953
A1 Gleason, Alec
A1 Richter, Florian
A1 Beller, Nathalia
A1 Arivazhagan, Naveen
A1 Feng, Rui
A1 Holmes, Emma
A1 Glicksberg, Benjamin S
A1 Morton, Sarah U
A1 Vega-Talbott, Maite La
A1 Fields, Madeline
A1 Guttmann, Katherine
A1 Nadkarni, Girish N
A1 Richter, Felix
YR 2024
UL http://medrxiv.org/content/early/2024/04/19/2024.04.17.24305953.abstract
AB Importance Infant alertness and neurologic changes are assessed by exam, which can be intermittent and subjective. Reliable, continuous methods are needed.Objective We hypothesized that our computer vision method to track movement, pose AI, could predict neurologic changes.Design Retrospective observational study from 2021–2022.Setting A level four urban neonatal intensive care unit (NICU).Participants Infants with corrected age ≤1 year, comprising 115 patients with 4,705 hours of video data linked to electroencephalograms (EEG), including 46% female and 25.2% white non-Hispanic.Exposures Pose AI prediction of anatomic landmark position and an XGBoost classifier trained on one-minute variance in pose.Main outcomes and measures Outcomes were cerebral dysfunction, diagnosed from EEG readings by an epileptologist, and sedation, defined by the administration of sedative medications. Measures of algorithm performance were receiver operating characteristic-area under the curves (ROC-AUCs) on cross-validation and on two test datasets comprised of held-out infants and held-out video frames from infants used in training.Results Infant pose was accurately predicted in cross-validation, held-out frames, and held-out infants (respective ROC-AUCs 0.94, 0.83, 0.89). Median movement increased with age and, after accounting for age, was lower with sedative medications and in infants with cerebral dysfunction (all P<5−10-3, 10,000 permutations). Sedation prediction had high performance on cross-validation, held-out frames, and held-out infants (ROC-AUCs 0.90, 0.91, 0.87), as did prediction of cerebral dysfunction (ROC-AUCs 0.91, 0.90, 0.76).Conclusions and Relevance We used pose AI to predict sedation and cerebral dysfunction in 4,705 hours of video from a large, diverse cohort of infants. Pose AI may offer a scalable, minimally invasive method for neuro-telemetry in the NICU.Key PointsQuestion: Can computer vision track infant movement and use movement patterns to predict neurologic changes in critically ill infants?Findings: In this retrospective study of 115 infants less than 1 year old, we trained a computer vision algorithm to track movement from video data and predict sedation and cerebral dysfunction.Meaning: Computer vision can monitor alertness and relevant neurologic changes in critically ill infants.Competing Interest StatementFlorian Richter is a co-founder and owns shares of FloDri Inc.Funding StatementThis study was funded by the Friedman Brain Institute Fascitelli Scholar Junior Faculty Grant and Thrasher Research Fund Early Career AwardAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of the Icahn School of Medicine at Mount Sinai gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAny non-identifiable data produced in the present study are available upon reasonable request to the authors